Genesystem Co., Ltd. (KOSDAQ:363250)
South Korea · Delayed Price · Currency is KRW 4,850.00
+35.00 (0.73%)
At close: Mar 6, 2026
Genesystem Market Cap
Genesystem has a market cap or net worth of 33.08 billion as of March 9, 2026. Its market cap has decreased by -52.96% in one year.
Market Cap
33.08B
Enterprise Value
35.79B
Revenue
345.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
4,850.00
Market Cap Chart
Since May 26, 2021, Genesystem's market cap has decreased from 118.51B to 33.08B, a decrease of -72.09%. That is a compound annual growth rate of -23.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 33.08B | 18.29% |
| Dec 30, 2025 | 27.96B | -52.89% |
| Dec 30, 2024 | 59.36B | -8.92% |
| Dec 28, 2023 | 65.17B | 12.35% |
| Dec 29, 2022 | 58.00B | -26.36% |
| Dec 30, 2021 | 78.77B | -33.54% |
| May 26, 2021 | 118.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| QuantaMatrix | 76.92B |
| Hironic | 74.74B |
| Neofect | 65.85B |
| JPI Healthcare | 62.80B |
| DRGEM | 56.11B |
| Genoray | 49.44B |
| UXN Co., Ltd. | 37.79B |
| CU Medical Systems | 32.02B |